← FDA Drug Approvals (Drugs@FDA)

LENALIDOMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DEVA HOLDING AS · Approved 2025-05-22

Drug application

FDA Application #

ANDA217554

Application type

Abbreviated New Drug Application (Generic)

Brand name

LENALIDOMIDE

Generic name

LENALIDOMIDE

Active ingredients

LENALIDOMIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

DEVA HOLDING AS

Manufacturer

Devatis Inc.

First approval

2025-05-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown